Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil

Summary

The purpose of this study is to confirm the efficacy and the safety of Avanafil 100mg, 200mg or placebo administered orally for 12 weeks in patients with erectile dysfunction. The efficacy is evaluated by IIEF, SEP Q2 and Q3 and GEAQ and the safety is evaluated by laboratory tests, vital signs, physical examination and adverse events.

Timeline

Start

2009-03

Primary completion

2009-10

Completion

2009-11

Drugs

Indications